Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 951-1000 of 1174 result(s).
CYDY CytoDyn Inc
06/06/2024 2:46:22 AM
A 2024 Mayo CRC CCR5 paper : Conclu (14)
CYDY CytoDyn Inc
06/05/2024 12:33:55 PM
I know, yep & on pills, Charlie She (1)
CYDY CytoDyn Inc
06/05/2024 11:37:15 AM
A May 7th, 2024 Colorectal CCR5 pap (12)
CYDY CytoDyn Inc
06/05/2024 10:43:11 AM
There is no boogeyman or was. Great (5)
CYDY CytoDyn Inc
06/05/2024 6:19:35 AM
Actually MGK, that's the 1st time C (6)
CYDY CytoDyn Inc
06/05/2024 2:31:45 AM
Longer acting LL comment(s) in-line (5)
CYDY CytoDyn Inc
06/04/2024 8:25:54 PM
Remember, it was Dr. J who press re (11)
CYDY CytoDyn Inc
06/04/2024 7:42:59 PM
"This new medication, however, has (16)
CYDY CytoDyn Inc
06/03/2024 10:20:57 AM
Funding from them & who the CRC par (1)
CYDY CytoDyn Inc
06/03/2024 9:50:36 AM
For couple yrs now, he's mentioned (2)
CYDY CytoDyn Inc
06/02/2024 4:11:28 PM
Just send Dr. J / Cytodyn, links to (7)
CYDY CytoDyn Inc
06/01/2024 10:02:15 AM
Hepatotoxicity: Severe drug-induced (2)
CYDY CytoDyn Inc
05/31/2024 10:09:42 AM
I will run through a lions den, wea (3)
CYDY CytoDyn Inc
05/31/2024 9:51:02 AM
Sp has done typical movements. Same (4)
CYDY CytoDyn Inc
05/31/2024 9:40:07 AM
Thank you Cytodyn team!! EOM. (4)
CYDY CytoDyn Inc
05/30/2024 5:00:06 PM
US Army was also @ the time going t
CYDY CytoDyn Inc
05/30/2024 4:23:43 PM
Sounds great...thx!!
CYDY CytoDyn Inc
05/30/2024 4:22:48 PM
2018/19...So amFAR is finally, back (2)
CYDY CytoDyn Inc
05/30/2024 3:00:54 PM
We uplist much quicker filing any A (2)
CYDY CytoDyn Inc
05/30/2024 1:31:39 PM
& quickest allowed is 2 days.
CYDY CytoDyn Inc
05/30/2024 1:00:51 PM
& no Q&A. Make sure nothing is over (1)
CYDY CytoDyn Inc
05/30/2024 10:15:06 AM
If not this call, then by the next, (1)
CYDY CytoDyn Inc
05/30/2024 9:01:45 AM
April 2018 & me either. But.....sha
CYDY CytoDyn Inc
05/30/2024 7:16:54 AM
4k yrs ago: But this glimpse into c (2)
CYDY CytoDyn Inc
05/30/2024 6:10:39 AM
Reminder... "(CRC) is the third mos (2)
CYDY CytoDyn Inc
05/29/2024 5:37:50 PM
2 yrs.... pre-covid that is.
CYDY CytoDyn Inc
05/29/2024 5:36:59 PM
For me, if partnering tmrw on prior
CYDY CytoDyn Inc
05/28/2024 10:30:38 PM
Quest ending, & a webinar. Well alr
CYDY CytoDyn Inc
05/28/2024 7:54:12 PM
Yep, 12 days ago the shareholder le (1)
CYDY CytoDyn Inc
05/28/2024 11:44:56 AM
"We will continue to review opportu (3)
CYDY CytoDyn Inc
05/27/2024 11:26:13 AM
Nice. Shall see....
CYDY CytoDyn Inc
05/26/2024 6:25:07 PM
sean007 -- that $10b could easily b (3)
CYDY CytoDyn Inc
05/26/2024 9:32:37 AM
1st trial interim readout is not ev (2)
CYDY CytoDyn Inc
05/24/2024 2:48:14 AM
FDA -- he obviously feels they too,
CYDY CytoDyn Inc
05/24/2024 1:08:51 AM
Overlooked about Dr. J leaving Ques (6)
CYDY CytoDyn Inc
05/23/2024 2:56:23 PM
Cytodyn should head hunt a well kno (1)
CYDY CytoDyn Inc
05/23/2024 11:31:31 AM
Of course it's LL expansion related (1)
CYDY CytoDyn Inc
05/23/2024 9:34:25 AM
The path comparisons are right ther (1)
CYDY CytoDyn Inc
05/23/2024 6:07:43 AM
Compare sp potential --- something (7)
CYDY CytoDyn Inc
05/22/2024 10:49:56 AM
chazzledazzle --- April 27, 2020 ex
CYDY CytoDyn Inc
05/22/2024 3:36:29 AM
Thought I attached -- https://www.c
CYDY CytoDyn Inc
05/22/2024 3:30:24 AM
Never said right now. People can't (4)
CYDY CytoDyn Inc
05/22/2024 12:05:14 AM
https://www.fiercepharma.com/pharm (1)
CYDY CytoDyn Inc
05/21/2024 11:01:07 PM
I remember them & this. 4 yrs past. (2)
CYDY CytoDyn Inc
05/21/2024 10:21:32 PM
Reply not in direct response, so gu
CYDY CytoDyn Inc
05/21/2024 9:06:00 PM
15.6.2: AI in the drug product cont (2)
CYDY CytoDyn Inc
05/18/2024 4:29:55 PM
Almost 3 months ago "by June" was c (3)
CYDY CytoDyn Inc
05/18/2024 4:16:20 PM
Almost 3 months ago we were told 1 (3)
CYDY CytoDyn Inc
05/18/2024 3:44:02 PM
your outta your mind -- take that c (1)
CYDY CytoDyn Inc
05/18/2024 2:51:37 PM
" It is imperative that the Company (2)
Go to page:
  • << First
  • < Previous
  • 19
  • 20
  • Next >

Recent Articles

  • Deliver Better Guest Service With a Hospitality LMS
  • Limited Edition British Lion Gold Bullion Coin Launches Soon
  • Significant Bitcoin Transfer Sparks New Mining Opportunities
  • The Growth Journey of Caterpillar: An Investment Perspective
  • Explore the Growth of $1000 Invested in RTX Over Five Years
  • Groq Expands AI Capabilities with New Helsinki Data Center
  • Furniture.com Launches $1,500 Giveaway for Back-to-School Fun
  • PCL Construction Strengthens Leadership for Data Center Growth
  • Strategic Acquisition Enhances Seneca's Industrial Labeling Business
  • Bartlett Enhances Agricultural Space with Ceres Acquisition
  • Stefan Szanto Elevated to Partner at Education Growth Partners
  • Alena Kharkavets Takes Charge as WTW's Claims Leader
  • Hims & Hers Health, Inc. Faces Lawsuit Over Safety Concerns
  • Investors Take Action: Vestis Corporation Financial Losses Explained
  • Aramis Group Gears Up for Fiscal Growth Despite Challenges
  • BNP Paribas Reshapes Leadership for Future Growth Strategy
  • Exploring Soitec's Share Structure and Voting Rights
  • Understanding Voting Rights for Company Shareholders
  • Ipsen's Latest Liquidity Agreement Update and Company Overview
  • Exosens' Liquidity Contract Insights in Latest Report
  • Exploring a Decade of Growth for Lowe's Companies Stock
  • Bonk's 58% Surge: Key Factors Behind Its Impressive Growth
  • Mullen Automotive's Strategies Amid EV Tax Credit Changes
  • Insights into 74Software's Latest Liquidity Contract Update
  • 74Software Liquidity Contract Report Showcases Performance
  • CrowdStrike Faces Downgrade as Analysts Show Caution
  • Understanding Matador Resources' P/E Ratio in Today's Market
  • Boeing's Options Activity: What It Means for Investors
  • Understanding Whale Investments in Rigetti Computing's Future
  • Understanding the Current Trading Dynamics of AST SpaceMobile
  • Tribe Property Technologies Completes Successful Public Offering
  • Hims & Hers Faces Challenges Amid Novo Nordisk Breakup
  • Redefining Sustainability: JELD-WEN's Green Innovations
  • Revolutionizing Patient Engagement: Health Union's AI Innovations
  • Sequana Medical Updates Share Capital and Share Count Metrics
  • Exploring Investment Strategies at the Global Family Office Summit
  • Exploring the Flourishing Fake Image Detection Market's Growth
  • PrideStaff Expands Reach by Relocating Office in Tempe
  • Miraterra's Strategic Acquisition Enhances Soil Health Solutions
  • Unlock Free BTC and Dogecoin Mining with OPTO Miner's New App
  • A Fresh Dining Experience at The Garden Restaurant Reopens
  • Discover the Future of Passive Crypto Income with XRP Mining
  • Innovative AI Solutions in Heart Failure Management with Expert Guidance
  • Shell's Strategic Share Buyback Program Enhances Investor Confidence
  • BCTCares Foundation Kicks Off Campaign to Fight Child Hunger
  • BNP Paribas Reinvents Governance to Enhance Strategic Outlook
  • Aramis Group Revises Growth Projections for Fiscal Year 2025
  • Voting Rights Declaration: Accountability on Key Metrics
  • Exosens Reports on Liquidity Contract with Kepler Cheuvreux
  • EMGS Reports Improved Vessel Activity and Sales Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site